The most common clinical phenotype associated with TBK1 mutations is FTD-MND rather than FTD alone, with the frequency in patient cohorts 3.0% to 4.5% and 0.5% to 1.1%, respectively [3], [4]. Here, TBK1 is linked to mild neurocognitive disorder.